Subcutaneous ibalizumab in at-risk healthy subjects [abstract].
Dec 30, 2014
30 Dec 2014
Ernst J, Keefer M, Lalezari J, et al.
Location
54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); September 5-9, 2014; Washington, DC, USA.